Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Comparing single-use and reusable duodenoscopes for treating biliary and pancreatic disorders

Official title: Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial

Run by Rush University Medical Center · NCT06895785 · Data updated 2026-11-12

This study is testing whether a single-use duodenoscope is safer and more effective than a reusable one for treating patients with biliary and pancreatic disorders.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment100 (estimated)
SponsorRush University Medical Center
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedFebruary 21, 2025
Main results expectedFebruary 2030
Study endsMay 2030
Registry record updatedMarch 26, 2025
Trial IDNCT06895785 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with biliary or pancreatic duct disorders confirmed by clinical symptoms and imaging.

Probably not a fit

Patients with altered pancreaticobiliary anatomy, pregnancy, or prior history of ERCP may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the Exalt Model disposable duodenoscope against a reusable duodenoscope in patients with biliary and pancreatic duct disorders. It focuses on assessing feasibility, ease of use, adverse events, crossover events, and infection rates associated with each type of duodenoscope. The study aims to address concerns regarding infection control and cross-contamination linked to reusable scopes, which have been associated with serious patient harm. By utilizing a single-use platform, the trial seeks to enhance patient safety and procedural effectiveness.

Why it matters

Potential benefit: If successful, this study could significantly reduce infection rates and improve patient outcomes during endoscopic procedures.

How similar studies have gone: Other studies have indicated that single-use endoscopes can reduce infection risks, suggesting a promising approach in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients \> 18 years old who have biliary or pancreatic duct disorder, based on clinical symptoms and radiological findings at CT or magnetic resonance cholangiopancreatography
* Native papilla

Exclusion Criteria:

* Patients with altered pancreaticobiliary anatomy
* Pregnancy
* Patients with percutaneous transhepatic biliary drainage
* Prior history of ERCP
* Inability to provide informed consent

Where it's running

  • Rush University Medical Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Neal A Mehta, MD — Rush University Medical Center
  • Study coordinator: Neal A Mehta, MD
  • Email: Neal_A_Mehta@rush.edu
  • Phone: 3129428651

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.